Search research articles
Contact Us
Filters
Showing results (71-80 of 97) with videos related to
Page
of 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1997
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine
V Bronte, M W Carroll, T J Goletz, et al.
Nature Medicine
|
July 8, 1999
Cancer therapy using a self-replicating RNA vaccine
H Ying, T Z Zaks, R F Wang, et al.
Cancer Research
|
April 15, 1995
Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses
B J McCabe, K R Irvine, M I Nishimura, et al.
Journal of the National Cancer Institute
|
January 29, 1999
Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen
Y C Xie, C Hwang, W Overwijk, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
July 1, 1994
Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines
F M Marincola, P Shamamian, T B Simonis, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1995
Defective major histocompatibility complex class I expression in a sarcomatoid renal cell carcinoma cell line
M K Jakobsen, N P Restifo, P A Cohen, et al.
Cancer Research
|
June 15, 1996
Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines
R S Chamberlain, M W Carroll, V Bronte, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 15, 1991
Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response
N P Restifo, F Esquivel, A L Asher, et al.
Cancer Research
|
July 15, 1995
Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes
L Rivoltini, K C Barracchini, V Viggiano, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
November 1, 1995
HLA associations in the antitumor response against malignant melanoma
F M Marincola, P Shamamian, L Rivoltini, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 97) with videos related to
Sort By:
Page
of 10
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1997
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine
V Bronte, M W Carroll, T J Goletz, et al.
Nature Medicine
|
July 8, 1999
Cancer therapy using a self-replicating RNA vaccine
H Ying, T Z Zaks, R F Wang, et al.
Cancer Research
|
April 15, 1995
Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses
B J McCabe, K R Irvine, M I Nishimura, et al.
Journal of the National Cancer Institute
|
January 29, 1999
Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen
Y C Xie, C Hwang, W Overwijk, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
July 1, 1994
Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines
F M Marincola, P Shamamian, T B Simonis, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1995
Defective major histocompatibility complex class I expression in a sarcomatoid renal cell carcinoma cell line
M K Jakobsen, N P Restifo, P A Cohen, et al.
Cancer Research
|
June 15, 1996
Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines
R S Chamberlain, M W Carroll, V Bronte, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 15, 1991
Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response
N P Restifo, F Esquivel, A L Asher, et al.
Cancer Research
|
July 15, 1995
Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes
L Rivoltini, K C Barracchini, V Viggiano, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
November 1, 1995
HLA associations in the antitumor response against malignant melanoma
F M Marincola, P Shamamian, L Rivoltini, et al.
Page
of 10